Immunologic disorders in posttransplant lymphoma: therapeutic implications.
Jacobs
U
U
Department of General Internal Medicine, University Hospital, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.
Niese
D
D
Brensing
K A
KA
Eis-Hübinger
A
A
Buszello
H
H
Klehr
H U
HU
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology; D016572:Cyclosporine / Q000627:therapeutic use; D006566:Herpesviridae Infections / Q000175:diagnosis; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016131:Lymphocyte Subsets / Q000276:immunology*; D016393:Lymphoma, B-Cell / Q000209:etiology / Q000276:immunology*; D008297:Male; D011183:Postoperative Complications; D011239:Prednisolone / Q000627:therapeutic use
D015703:Antigens, CD; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine